当前位置:
X-MOL 学术
›
Eur. Heart J.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
First-in-man implantation of a pre-packaged self-expandable dry-tissue transcatheter aortic valve
European Heart Journal ( IF 37.6 ) Pub Date : 2017-10-31 , DOI: 10.1093/eurheartj/ehx587 Yuan Feng 1 , Zhen-Gang Zhao 1 , Jorge Baccaro 2 , Min Frank Zeng 3 , R David Fish 4 , Mao Chen 1
European Heart Journal ( IF 37.6 ) Pub Date : 2017-10-31 , DOI: 10.1093/eurheartj/ehx587 Yuan Feng 1 , Zhen-Gang Zhao 1 , Jorge Baccaro 2 , Min Frank Zeng 3 , R David Fish 4 , Mao Chen 1
Affiliation
Transcatheter aortic valve implantation (TAVI) has become the mainstay of treatment for aortic stenosis. Reasonable extension of TAVI utilization into a broader group, however, would mandate further device refinement.
中文翻译:
预包装的可自我扩张的干组织经导管主动脉瓣的首次人为植入
经导管主动脉瓣植入术(TAVI)已成为主动脉瓣狭窄的主要治疗手段。但是,将TAVI的使用合理地扩展到更广泛的人群中将要求进一步完善设备。
更新日期:2017-10-31
中文翻译:
预包装的可自我扩张的干组织经导管主动脉瓣的首次人为植入
经导管主动脉瓣植入术(TAVI)已成为主动脉瓣狭窄的主要治疗手段。但是,将TAVI的使用合理地扩展到更广泛的人群中将要求进一步完善设备。